TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TECH

Bio-Techne Corp

Healthcare · Biotechnology

72.40$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 95 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TECH
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
26 42 25 51 45 39 22 65 39 47 40 56 41 70 49 45 66 89 75 122 48 101 73 103 56 64 51 83 59 83 81 75 64 84 41 98 28 82 87 95 292
14 16 16 15 15 16 16 17 19 20 19 20 20 21 21 21 21 21 21 25 25 25 25 26 27 27 27 27 29 28 27 28 28 27 28 27 24 25 24 24 97
3.2 4.1 4.0 3.4 3.8 5.0 4.7 15 12 6.9 5.7 8.1 8.4 10 7.9 6.0 13 16 11 9.8 12 14 8.1 8.4 14 17 10 -2.1 10 26 8.1 7.1 10 15 11 4.6 12 14 10 5.2 41
8.4 15 -15 -5.5 3.8 -33 -8.2 -1.5 11 2.6 4.6 3.0 7.9 26 0.1 10 17 29 3.5 46 -46 -58 8.9 -61 -60 15 -6.0 -7.7 – – – – – – – – – – – – –
-12 4.6 -11 5.1 3.7 -2.9 -6.4 7.5 -10.0 -0.1 -16 -1.5 -13 27 -7.8 -11 -5.4 12 -13 36 -54 12 -35 6.9 -23 -17 -39 82 2.1 19 1.3 -10 -9.7 12 -12 22 -43 43 -4.1 22 18
2.4 2.9 4.0 5.9 5.3 6.3 3.5 5.8 4.2 4.6 4.9 12 11 15 9.3 17 11 11 11 11 6.1 10 15 14 9.6 6.1 12 11 14 15 16 18 9.2 6.8 10 4.9 5.4 5.9 9.1 8.5 29
-268 -33 0.0 -4.7 -12 -6.3 -58 38 -288 -14 -4.7 -30 -15 33 19 -10 -8.1 -8.6 0.1 -227 -7.1 -35 -36 -19 -20 -0.1 -241 -4.8 -154 -24 -16 -8.8 -22 -5.0 -8.9 0.4 0.6 -5.9 -5.8 -7.1 -18
12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 13 13 13 13 13 13 13 13 13 13 13 13 13 13 12 12 12 13 12 50
2.0 0.1 1.5 1.6 0.0 6.7 7.0 5.4 16 -15 0.0 0.0 9.0 18 -50 32 – 32 -43 -19 -23 -41 -61 -59 -20 5.0 4.4 8.4 -20 -80 -0.2 -0.4 – -76 -100 -100 0.0 0.0 0.0 -42 -42
252 -0.1 0.1 252 -6.0 19 30 -54 220 -13 -23 -17 -19 -103 37 -63 -33 -125 -16 126 -41 -18 -23 -3.1 8.7 -65 170 -20 – – – – -19 0.0 30 16 -46 -40 -60 0.0 -146
242 -12 -24 -17 -51 16 -1.0 -63 223 -41 -27 -20 -24 -97 -18 -45 -35 -90 -55 118 -40 -53 -84 -66 -32 -72 151 -24 72 -81 -52 -60 -12 -84 -68 -90 -44 -49 -43 -33 -169
5.4 -11 0.9 32 -19 49 -35 35 -27 -8.8 9.7 5.3 -1.0 10 46 -9.6 23 -3.9 21 13 -2.8 16 -51 12 -7.3 -0.6 -37 53 -32 -19 9.8 12 36 -10.0 -37 22 -17 28 37 55 103
24 39 21 45 39 33 18 59 35 42 35 44 30 56 40 27 55 78 64 111 42 91 58 89 47 58 39 73 46 68 65 58 55 78 31 93 22 76 78 87 263

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?